摘要
目的:评价依达拉奉注射液治疗急性脑梗死(ACI)的疗效。方法:采用随机对照试验,选择发病72 h内的急性脑梗死患者60例,随机分为依达拉奉组(30例)及对照组(30例)。治疗前和治疗后1月对患者进行神经功能缺损(natuonal instituteofhealth stroke scale,NIH-SS)评分,Fugl-Meger评分或Barthel指数比较作为主要疗效判断标准。结果:治疗后30 d依达拉奉组NIHSS评分(3.71±2.43)较对照组(7.86±3.65)降低明显,差异具有统计学意义(P<0.05)。治疗30 d后,2组患者的Fugl-Meger评分及Barthel指数均明显提高,但依达拉奉组提高幅度明显大于对照组,表明依达拉奉组患者神经功能缺损恢复程度优于对照组。结论:依达拉奉是一种治疗急性缺血性脑卒中有效的神经保护剂。
Objective:To investigale the effects of edaravone or acute cerebral infartion(ACI).Methods:Arandomized,controlled.study was performed.forty patients,who had an onset of ACIwith 72hours where allocated to edaravone group(n=20)or the control group(n=20).randomly Before treatment and 30days after treatment,the neurological deficits(NIHSS),FUgl-Meger andBarthel index were evaluated.Results: There were significant differences between edaravone group(3.71±2.43)and control group(7.86±3.65).Thirty days after treatm...
出处
《中国民康医学》
2008年第3期210-211,共2页
Medical Journal of Chinese People’s Health
